Secondary amenorrhoea is not an uncommon problem, and the investigation of such patients requires a general physical examination includinga gynaecological examination to exclude pelvic causes. laboratory imestigation consists of simple routine biochemistry tests followed by endocrine tests to exclude non-endocrine and endocrine disorders. In the absence of specific signsand symptoms, biochemicalinvestigation should be carried out in a step-wise manner to exclude the more common causes first, and proceeding to less common causes thereafter. We present a case to illustrate some common mistakes made in the endocrine investigation of such patients and a suggested algorithm to aid in their systemic investigation.
CASE HISTORY
A 28-year-old woman was referred by her general practitioner for investigation of post-natal amenorrhoea of Consultant chemical pathologist, Newham General Hospital, London E13 8RU, England 3 Mayne P. Clinical Chemistry in Diagnosis and Treatment, 6th edn. London: Edward Arnold, 1995 8 months duration following the birth of her first baby. There was no significant past medical or obstetric history, and there had been an uneventful pregnancy and delivery. The baby was normal and bottle fed. Breast feeding was not established but it was not clear whether there was a difficulty in establishing breast feeding or whether the bottle was simply the preferred method of feeding. At the time of presentation, she was otherwise quite fit, her primary concern being the failure of normal resumption of periods after delivery.
Clinical examination including pelvic examination did not reveal any abnormality. The laboratory investigations requested by the clinical team were thyroid function tests, follicle-stimulating hormone/luteinizing hormone (FSH/ LH) and 24 h urine cortisol in addition to routine electrolytes, liver function tests and glucose which were all normal. The results of the endocrine tests were a low free-thyroxine 5.1 pmol/l (10.3-25.8), normal thyrotropin 2.7 IU/I (0.2--4.0), FSH normal 7.8 IU/I, LH low normal 1.8IU/1 and 24h urinary cortisol low 9nmol/24h (127-363). The 24h urine volume was low and was 400ml.
On the basis of these results, the laboratory assayed serum cortisol which was low 42 nmol/l (50-600), oestradIol which was low 2 pmol/l (110-700) and prolactin which was normal 87 IU/l (up to 425). The results were reported by the laboratory as suggestive of a need for review of pituitary function.
The patient was seen 2 months later in the clinic, still amenorrhoeic, and was given Provera 5 mg three times a day Yes or no (remember signs and symptoms may not always be apparent)
• for 5 days which failed to produce withdrawal bleeding. She was seen again 3 months later and given Primolut N 5 mg for 7 days.which also failed to lead to withdrawal bleeding. She was lost to follow up for a further 3 months until she was suddenly admitted as an emergency with fever and diagnosed as '?malaria' She was treated symptomatically and given replacement therapy with hydrocortisone and thyroxine to which she responded well. She also underwent dynamic pituitary function tests which confirmed the diagnosis of panhypopituitarism. Computerized tomography scan of the pituitary fossa was normal and hence diagnosed as 'idiopathic hypopituitarism'. She was commenced on long-term replacement therapy.
DISCUSSION AND CONCLUSION
The lessons to be learned from the management of this case are: The presence of a low free T4 with normal thyroid stimulating hormone (TSH) may be the first indication of a possible underlying pathology 2 Laboratories using TSH as a preliminary screen for investigating thyroid function would inevitably miss such cases 3 All patients with a daytime cortisol of less than 150nmolll in such instances should be investigated further 4 Investigation of amenorrhoea/oligomenorrhoea in women aged less than 45 should always be accompanied by serum oestradiol if gonadotrophins are not suggestive of primary ovarian failure to exclude a pituitary lesion 5 Normal or low normal serum gonadotrophins do not exclude hypopituitarism 6 Urinary cortisols are of less value in the investigation of such cases unless Cushing's syndrome is suspected and should be investigated by serum cortisoIs preferably as part of a dynamic stimulation test 7 Oestrogen/progesterone administration for withdrawal bleeding is of no value in the presence of an obvious hypo-oestrogenic state 8 The key to successful management of patients with panhypopituitarism is speed, and all efforts must be made to avoid delaying diagnosis and treatment. Thyroxine therapy should be deferred until adequate cortisol therapy has been instituted. 
